7 August 2018

#KCR_QoM: Question of the Month – July Results

In July, we asked our visitors for their opinions regarding the potential for patient recruitment across different regions of the world. About half the participants in our survey (49%) declared they see the largest potential in Central and Eastern Europe (CEE). Almost tied in second and third place, our respondents chose the Asia-Pacific region (26.5%) and Latin America (24.5%).

It is no surprise that CEE is the region with the highest perceived potential. The closeness of the region to Western Europe (a hub for pharma Research & Development), a clear regulatory environment, coupled with a fairly developed health infrastructure and a highly educated healthcare force makes the region an interesting place to conduct clinical trials.

On the other hand, while the Asia-Pacific region and Latin America are attractive in terms of population, both markets face daunting challenges for the recruitment of patients for a number of reasons, including a lack of specialized medical infrastructure and an insufficient legal framework that protects both patients and intellectual property.

Stay tuned for the Question of the Month in September!


Results #KCR_QoM from previous months:

June 2018 - What is the future of pharma/CRO industry events?

May 2018 - What is the future of the Functional Service Provision (FSP) business?

April 2018 - What technology will have the biggest impact on clinical trials execution in the next 3 years?

March 2018 - Consolidation in the CRO industry makes my work...


Media Contact

Joanna Lewandowska
Associate Director, PR & Marketing
mobile: (+48) 605 053 164